Mark (Qizhou) Qin Buys 90,830 Shares of EZZ Life Science Holdings Limited (ASX:EZZ) Stock

EZZ Life Science Holdings Limited (ASX:EZZ) insider Mark (Qizhou) Qin purchased 90,830 shares of the stock in a transaction on Wednesday, December 11th. The shares were purchased at an average cost of A$2.71 ($1.73) per share, for a total transaction of A$246,149.30 ($156,782.99).

EZZ Life Science Stock Performance

The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.53 and a current ratio of 5.96.

EZZ Life Science Increases Dividend

The company also recently announced a Final dividend, which was paid on Sunday, December 8th. Stockholders of record on Sunday, December 8th were issued a $0.02 dividend. This represents a dividend yield of 0.57%. The ex-dividend date of this dividend was Monday, November 4th. This is a positive change from EZZ Life Science’s previous Final dividend of $0.01. EZZ Life Science’s dividend payout ratio (DPR) is 37.50%.

About EZZ Life Science

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand.